EGFR and neoplasm: Single-chain variable fragment (scFv) antibodies against CD3 and EGFR The single-chain fragment variable (scFv), which contains the complete antigen-binding domains of a whole antibody, possesses numerous advantages, including high specificity and affinity for antigens, low immunogenicity, and the ability to penetrate and diffuse through tumor tissues [238].